Bibliografia UJ CM

1/4
Brendan P. Hodkinson, Michael Schaffer, Joshua D. Brody, Wojciech Jurczak, Cecilia Carpio, Dina Ben-Yehuda, Irit Avivi, Ann Forslund, John Alvarez, Rob Ceulemans, Nele Fourneau, Anas Younes, Sriram Balasubramanian.
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation.
Translational Oncology
2021 : Vol. 14, nr 1, il., bibliogr. 68 poz., abstr.
Autor korespondencyjny: Sriram Balasubramanian.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 1936-5233
AZ
ORG
AIF
IF: 4.803
Adres url:
Streszczenie w PubMed:
2/4
David J. Straus, Monika Długosz-Danecka, Sergey Alekseev, Arpad Illes, Marco Picardi, Ewa Lech-Maranda, Tatyana Feldman, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Jan Walewski, Radhakrishnan Ramchandren, Pier Luigi Zinzani, Martin Hutchings, Joseph M. Connors, John Radford, Javier Munoz, Won Seog Kim, Ranjana Advani, Stephen M. Ansell, Anas Younes, Harry Miao, Rachael Liu, Keenan Fenton, Andres Forero-Torres, Andrea Gallamini.
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma : 3-year update of the ECHELON-1 study.
Blood
2020 : Vol. 135, nr 10, s. 735-742, il., bibliogr. 19 poz., abstr.
Auto korespondencyjny: David J. Straus.
p-ISSN: 0006-4971
AZ
ORG
AIF
IF: 22.113
Adres url:
3/4
Anas Younes, Laurie H. Sehn, Peter Johnson, Xiaonan Hong, Jun Zhu, Caterina Patti, David Belada, Olga Samoilova, Cheolwon Suh, Sirpa Leppa, Shinya Rai, Mehmet Turgut, Wojciech Jurczak, Matthew C. Cheung, Ronit Gurion, Su-Peng Yeh, Andres Lopez-Hernandez, Ulrich Duhrsen, Catherine Thieblemont, Carlos Sergio Chiattone, Sriram Balasubramanian, Jodi Carey, Grace Liu, Martin Shreeve, Steven Sun, Sen Hong Zhuang, Jessica Vermeulen, Louis M. Staudt, Wyndham Wilson.
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Journal of Clinical Oncology
2019 : Vol. 37, nr 15, s. 1285-1295, bibliogr., abstr.
Autor korespondencyjny: Anas Younes.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 32.956
Adres url:
Streszczenie w PubMed:
4/4
Anas Younes, Joshua Brody, Cecilia Carpio, Armando Lopez-Guillermo, Dina Ben-Yehuda, Burhan Ferhanoglu, Arnon Nagler, Muhit Ozcan, Irit Avivi, Francesc Bosch, Maria Dolores Caballero Barrigon, Andrzej Hellmann, Bryone Kuss, David D.F. Ma, Fatih Demirkan, Munci Yagci, Netanel A. Horowitz, Paula Marlton, Raul Cordoba, Tomasz Wrobel, Daniela Buglio, Michael Streit, Brendan P. Hodkinson, Michael Schaffer, John Alvarez, Rob Ceulemans, Sriram Balasubramanian, Jan de Jong, Shean-sheng Wang, Nele Fourneau, Wojciech Jurczak.
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Lancet. Haematology
2019 : Vol. 6, nr 2, s. e67-e78, bibliogr., abstr.
Autor korespondencyjny: AnasYounes.
p-ISSN: 2352-3026
AZ
ORG
AIF
IF: 10.406
Adres url:
Streszczenie w PubMed:
DOI:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ